undefined undefined
NaN.000
NaN.00%
Cullinan Oncology press release (NASDAQ:CGEM): Q1 net loss $37.3 million. R&D expenses $30.6 million. G&A expenses $12.3 million. Cash, cash equivalents, investments, and interest receivable $434.8 mi...
05-16 23:10
Wedbush analyst Robert Driscoll reiterates Cullinan Therapeutics (NASDAQ:CGEM) with a Outperform and maintains $36 price target.
05-16 20:22
Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Cullinan Mana...
05-16 19:55
The latest update is out from Cullinan Management (CGEM). David Meek has been a...
05-16 04:45
本文来源:时代财经 作者:文若楠 2016年,王劲松从老东家赛诺菲辞职,创立和铂医药(02142.HK)。这位前赛诺菲中国研发中心总裁一下子成了“三无人员”...
05-10 09:00
Investor sentiment about a stock can dramatically swing to the positive or nega...
05-02 16:42
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Mo...
04-29 22:47
Biopharmaceutical company Cullinan Therapeutics (NASDAQ:CGEM) said on Monday that Mary Kay Fenton has been appointed CFO, beginning April 29. Fenton, most recently, served as interim CEO and CFO at Ta...
04-29 19:58
Cullinan Management (CGEM) just unveiled an announcement. Cullinan Therapeutics...
04-29 19:22
Cullinan Therapeutics (NASDAQ:CGEM) drew Wall Street's attention last week as William Blair touted the stock after peer-reviewed data for Amgen's (NASDAQ:AMGN) leukemia therapy, Blincyto, which target...
04-28 03:39